<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To assess risk for subclinical <z:hpo ids='HP_0004929'>coronary atherosclerosis</z:hpo> using electron beam- computed tomography in subjects with or without <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance (NGT) or <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT/impaired fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> [IFG]) or type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: We categorized <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance by type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> therapy (diagnosed <z:mp ids='MP_0002055'>diabetes</z:mp>) or with an oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test (OGTT) (IFG, IGT, and OGTT-detected <z:mp ids='MP_0002055'>diabetes</z:mp>) and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> as an elevated fasting insulin level, in subjects attending the fifth examination (1991-1995) of the Framingham Offspring Study </plain></SENT>
<SENT sid="2" pm="."><plain>A representative subset of subjects without clinical <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> was selected for electron beam computed tomography in 1998-1999 from age- and sex-stratified quintiles of the Framingham risk score </plain></SENT>
<SENT sid="3" pm="."><plain>The presence of subclinical <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> was defined as the upper quartile of the Agatston score distribution (score &gt; 170) </plain></SENT>
<SENT sid="4" pm="."><plain>We assessed risk for subclinical <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> using multivariable logistic regression </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Of 325 subjects aged 31-73 years, 51% were men, 11.2% had IFG/IGT, and 9.9% had <z:mp ids='MP_0002055'>diabetes</z:mp> (2.8% with diagnosed <z:mp ids='MP_0002055'>diabetes</z:mp>); 14.5% had <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Compared with NGT, subjects with IFG/IGT tended to be more likely (adjusted odds ratio 1.5, 95% CI 0.7-3.4) and those with <z:mp ids='MP_0002055'>diabetes</z:mp> were significantly more likely (2.7, 1.2-6.1) to have subclinical <z:hpo ids='HP_0004929'>coronary atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>In age- and sex-adjusted models, subjects with <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> were more likely to have subclinical <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> than those without <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> (2.1, 1.01-4.2), but further risk factor adjustment weakened this association </plain></SENT>
<SENT sid="8" pm="."><plain>In adjusted models including <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, <z:mp ids='MP_0002055'>diabetes</z:mp> remained associated with risk for subclinical <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> (2.8, 1.2-6.7); diagnosed <z:mp ids='MP_0002055'>diabetes</z:mp> (6.0, 1.4-25.2) had a larger effect than OGTT-detected <z:mp ids='MP_0002055'>diabetes</z:mp> (2.1, 0.8-5.5) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Individuals with <z:mp ids='MP_0002055'>diabetes</z:mp> have an elevated burden of subclinical <z:hpo ids='HP_0004929'>coronary atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Aggressive clinical <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> prevention is warranted, especially in diagnosed <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>